Related Experiment Video
Updated: Jun 8, 2026

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures
Published on: July 2, 2014
Structural and functional abnormalities of the amygdala in schizophrenia
Stephen M Lawrie1, Heather C Whalley, Dominic E Job
1Edinburgh University, Department of Psychiatry, Kennedy Tower, Royal Edinburgh Hospital, Edinburgh, Scotland, UK. s.lawrie@ed.ac.uk
Structural brain imaging reveals reduced amygdala-hippocampal complex volumes in adolescents at high risk for schizophrenia. These reductions may worsen with disease onset, indicating potential early developmental disturbances.
Area of Science:
- Neuroimaging and psychiatry
- Developmental neuroscience
- Schizophrenia research
Background:
- Schizophrenia involves positive symptoms (delusions, hallucinations) and negative symptoms (apathy, lack of motivation).
- Structural magnetic resonance imaging (sMRI) studies consistently show reduced limbic and paralimbic brain volumes in schizophrenia patients.
- The Edinburgh High-Risk Study (EHRS) investigates neurodevelopmental trajectories in individuals with a high genetic risk for schizophrenia.
Purpose of the Study:
- To examine pre-morbid brain volume differences in adolescents at high risk for schizophrenia.
- To investigate the relationship between brain volume changes and the onset of schizophrenic symptoms.
- To explore genetic and environmental influences on brain structure in schizophrenia.
Main Methods:
- Structural magnetic resonance imaging (sMRI) for volumetric analysis of brain structures, including the amygdala-hippocampal complex (AHC).
- Longitudinal assessment of initially healthy adolescents with a high familial risk for schizophrenia (EHRS).
- Neuropsychological testing to assess cognitive function and symptom development.
Main Results:
- Reduced amygdala-hippocampal complex (AHC) volumes were observed in high-risk adolescents prior to illness onset.
- AHC volumes in high-risk individuals were lower than controls but not yet at schizophrenic levels.
- Genetic factors appear to influence AHC volumes, particularly in families with dominant transmission patterns.
- Prefrontal lobe and basal ganglia volumes correlate with genetic liability in the general high-risk population.
- Temporal lobe volumes may decrease during psychosis onset, potentially influenced by drug abuse and stress.
Conclusions:
- Pre-morbid reductions in AHC volume suggest early developmental disturbances in individuals at high risk for schizophrenia.
- Further volume reductions may be associated with the transition to schizophrenia.
- Genetic liability influences various brain structures, including prefrontal and basal ganglia volumes.
- Temporal lobe changes may occur later, potentially linked to symptom development and environmental factors.
More Related Videos
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Functional Brain Systems: Limbic System
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Role of Amygdala in Memory
One of the...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Alzheimer Disease ll: Pathophysiology